Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Verona Pharma
Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators.
IPO Date: April 24, 2017
Sector: Healthcare
Industry: Biotech
Market Cap: $9.19B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.40 | 2.76%
Avg Daily Range (30 D): $0.07 | 0.06%
Avg Daily Range (90 D): $0.43 | 0.45%
Institutional Daily Volume
Avg Daily Volume: .45M
Avg Daily Volume (30 D): .91M
Avg Daily Volume (90 D): 2.59M
Trade Size
Avg Trade Size (Sh.): 108
Avg Trade Size (Sh.) (30 D): 131
Avg Trade Size (Sh.) (90 D): 169
Institutional Trades
Total Inst.Trades: 2,392
Avg Inst. Trade: $3.3M
Avg Inst. Trade (30 D): $4.09M
Avg Inst. Trade (90 D): $5.7M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $2.97M
Avg Closing Trade (30 D): $6.48M
Avg Closing Trade (90 D): $6.09M
Avg Closing Volume: 52.46K
   
News
Oct 6, 2025 @ 8:05 PM
Acquisition of Verona by MSD Approved by the High ...
Source: Globe Newswire
Sep 24, 2025 @ 8:05 PM
Shareholders of Verona Pharma Approve Proposed Acq...
Source: Globe Newswire
Sep 16, 2025 @ 10:00 AM
Verona Pharma to Present Additional Analyses of th...
Source: Verona Pharma
Sep 3, 2025 @ 5:00 PM
PDE4B Inhibitor Market Poised for Strong Growth by...
Source: Delveinsight
Aug 5, 2025 @ 5:00 PM
Global Chronic Obstructive Pulmonary Disease Treat...
Source: Delveinsight
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $.02 $-.02
Diluted EPS $.02 $-.02
Revenue $ $ 103.14M $ 76.26M
Gross Profit $ $ $
Net Income / Loss $ $ 11.92M $ -16.32M
Operating Income / Loss $ $ 13.31M $ -10.32M
Cost of Revenue $ $ $
Net Cash Flow $ $ 36.6M $ 1.66M
PE Ratio